AUG 20, 2018 10:20 AM PDT

Antidepressants Restore Inhibitory Neurons in Mice

WRITTEN BY: Nouran Amin

The capacity of brain cells to change is referred to as "plasticity” and according to a new study a decline in plasticity is associated with sensory and cognitive decline from the process of normal brain aging.

 

Now, scientists at MIT's Picower Institute for Learning and memory showed that inhibitory interneurons in the visual cortex of mice remained equally abundant during aging however, their arbors are more simplified and less dynamic.

Fortunately, the research study published in the Journal of Neuroscience explains that a significant degree of plasticity loss in mice was restored eventually using an antidepressant drug. The antidepressant drug is very common and known as “Prozac”.

Image Credit: CloudFront.net

Antidepressants work to ameliorate the age-related decline in the structural and functional plasticity of the visual cortex neurons. Despite common belief, loss of neurons due to cell death is quite limited during normal aging and unlikely to account for age-related functional impairments," the scientists explained including lead author of the study, Ronen Eavri. "Rather it seems that structural alterations in neuronal morphology and synaptic connections are features most consistently correlated with brain age, and may be considered as the potential physical basis for the age-related decline.

"Our finding that fluoxetine treatment in aging mice can attenuate the concurrent age-related declines in interneuron structural and visual cortex functional plasticity suggests it could provide an important therapeutic approach towards mitigation of sensory and cognitive deficits associated with aging, provided it is initiated before severe network deterioration.”

Source: Picower Institute at MIT

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 14, 2018
Drug Discovery
MAY 14, 2018
Gilenya: First Treatment for Pediatric MS
   A drug known as Gilenya (fingolimod), which was first approved in 2010 for the treatment of Multiple Sclerosis (MS) in adult patients, was rec...
JUN 27, 2018
Drug Discovery
JUN 27, 2018
Cannabis-Based Therapy Drug For The Treatment of Epilepsy
A drug derived from marijuana has been the first to be approved by the U.S. Food and Drug Administration for the treatment epilepsy. The drug, which will b...
JUL 09, 2018
Cell & Molecular Biology
JUL 09, 2018
Scientists Found a New Way to Treat Lung Cancer
Small cell lung cancer is an aggressive type that can be fatal; there were few treatments for the disease. That may have changed....
JUL 24, 2018
Drug Discovery
JUL 24, 2018
The Chili Pepper Drug Aims To Combat Obesity
A new drug was recently developed based on capsaicin, the compound found in chili peppers that is responsible for their spicy properties, was seen to cause...
JUL 31, 2018
Drug Discovery
JUL 31, 2018
DNA For Drug Development?
Genetic data of individuals who were customers of DNA testing service for the purpose of understanding their ancestry and genetic history, such as the comp...
AUG 14, 2018
Drug Discovery
AUG 14, 2018
Anticancer Drugs Help Plants Fight Infection
Drugs used for cancer treatments may now help plants fight diseases. A study conducted at Washington State University (WSU), by two plant pathologists&mdas...
Loading Comments...